STZ — Constellation Brands, Inc.

The mood is clearly negative: as of 2026-10-07 the stock closed at $118.98, barely above its 52-week low of $110.60 and ~29% below the 52-week high, despite four consecutive EPS beats and reaffirmed FY27 comparable EPS guidance of $11.20–$11.90. Bears point to soft U.S. beer-category depletions, a pressured Hispanic and low-to-middle-income consumer base, a still-shrinking wine and spirits top line (revenue -11.3% YoY in the Feb 2026 quarter, -9.8% in the Nov 2025 quarter), and Q2 FY27 operating margin of 30.6% versus 35.2% a year ago. The analyst mix captures the stalemate — 24 buy, 20 hold, 1 sell — even though the $160.54 consensus target implies ~35% upside.

Revenue went through a real reset, not an organic collapse: quarterly revenue slid from $2,918.7M in the quarter ended Aug 2024 to $1,920.2M by Feb 2026 (-11.3% YoY) as the mainstream wine brands were divested and wine/spirits shrank — but the last two quarters show a clear inflection, with Q1 FY27 (May 2026) down only 3.3% YoY and Q2 FY27 (Aug 2026) up 6.1% YoY to $2,633.0M, helped by +5.5% beer shipment volumes and ~20% Pacifico growth. Margins are mixed rather than steadily deteriorating: gross margin of 52.9% in the Aug 2026 quarter is up from ~51% two years ago (and the 54.3% posted in May 2026 was the best in the dataset), but operating margin compressed hard YoY — 30.6% in Q2 FY27 vs 35.2% in Q2 FY26 — so +6.1% revenue came with operating income down 7.9%, the biggest yellow flag in the trend. GAAP earnings are heavily distorted by one-offs (net losses of -$1,199M in Q2 FY25 and -$375M in Q4 FY26 from impairments/writedowns), so the cleaner read is Q2 FY27 GAAP EPS of $3.32 versus $2.65 a year earlier, on $3.74 adjusted. The genuinely anomalous line is cash: Q2 FY27 operating cash flow was -$661.8M and free cash flow -$839.0M versus +$852.1M OCF in the year-ago quarter — a ~$1.2B negative accrual swing (accruals ratio +5.56% of assets as of 2026-08-31) that either reverses in H2 or is a real earnings-quality problem.

Cheap on every static measure and cheap against its own history — but cheap for identifiable reasons. As of 2026-10-07: trailing P/E 10.66x versus a ~21.4x 5-year average (provider used only 2 years) and a ~28x 5-year median cited in the brief; PEG 0.17; forward P/E of ~10.3x on the $11.55 midpoint of FY27 comparable EPS guidance; P/S 2.21x versus a 3.99x 5-year average; dividend yield 3.1% versus a historical norm closer to 1.5%; ROE 20.9% and operating margin 30.9%. Two caveats: the reported 6.26x EV/EBITDA is understated because the balance-sheet feed shows long-term debt of $0 at 2026-08-31 (it was $9.09B the prior quarter) — add ~$9.0B of net debt to the $20.3B market cap and the truer figure is about 9x on ~$3.3B EBITDA, still below branded-beverage peers. The discount is the market asserting that the ~$11 EPS run rate is a peak rather than a base.

Earnings are winning; the price isn't — and that gap is the whole trade. STZ has beaten EPS four quarters running (Q2 FY27: $3.74 adjusted vs ~$3.55 consensus, revenue $2.63B vs ~$2.54B) and reaffirmed FY27 comparable EPS of $11.20–$11.90 while hinting September momentum could push toward the high end, yet the stock was down 9.76% in the month to 2026-10-07 and 24.81% over six months. The market is therefore not pricing the guidance — it is pricing a durable deceleration (soft depletions, a pressured core consumer) and treating current EPS as peak-cycle. Practically: if you believe the volume trend (Pacifico +20%, total beer shipments +5.5%) and the wine/spirits profit recovery hold, you are buying ~$11.5 of earnings at ~10x with a re-rating path to 13–14x; if volumes roll over, 10x is not a floor, because the E falls with them.

As of 2026-10-07 the tape is still bearish, not yet reversed: RSI(14) 37.02, price 1.76% below the 20-day SMA, 8.5% below the 50-day, and 19.1% below the 200-day, with 6-month and 3-month returns of -24.81% and -12.21%. The one constructive data point is the 1-week +2.57% move to $118.98 — above the $110.60 52-week low — following the 6 October print, an early attempt at a base, but RSI in the high 30s is weak rather than oversold and there is no higher-low or 50-day reclaim yet. Timing implication: this is a value-hunter's setup, not a momentum one — waiting for a close above roughly $130 (50-day area) or a successful retest of $110–113 would confirm the bottom rather than averaging into a falling knife.

• U.S. consumer softness: persistent inflation and compressed discretionary budgets among lower-to-middle-income and Hispanic households are suppressing off-premise alcohol depletions — the core demand driver for Modelo, Corona and Pacifico.
• Interest-rate environment: elevated rates have compressed multiples across consumer staples, and STZ's 0.4 beta means it offers little portfolio hedge while staples stay out of favor, while still carrying roughly $9B of debt to service.
• Tariffs on Mexican imports: STZ brews essentially all of its beer in Mexico, making tariff policy a direct gross-margin risk; the wine/spirits swing back to profit was partly aided by tariff recoveries, a non-repeating tailwind.
• Input-cost normalization: packaging, aluminum and agricultural costs have stabilized after two inflationary years, providing a modest margin tailwind that supports the 53% gross margin level.
• Category and regulatory pressure: GLP-1 adoption, moderation trends among younger drinkers and evolving alcohol labeling/health guidance are structural headwinds for the entire alcohol complex, not just STZ.

• Holiday retail off-take (November–December) — the key read on whether Pacifico's ~20% growth and total beer shipment growth of +5.5% are durable into calendar 2027.
• SpikedAde spiked-RTD integration and distribution scale-up through Gold Network distributor partners ($75M upfront plus contingent payments, announced 2026-10-06).
• Continued Wine & Spirits operating-profit recovery from cost optimization and tariff recoveries, which would remove the segment's drag on consolidated margins.
• Debt paydown (long-term debt fell from $10.28B in Nov 2025 to $9.09B in May 2026) lowering interest expense and mechanically lifting EPS.
• Multiple re-rating if beats continue: FY27 guidance migrating to the high end ($11.90) and any evidence that off-premise depletions have bottomed.

• Volume and pricing risk: the Mexican beer franchise is the profit engine, flagship brands already showed 'minor volume friction,' and the U.S. category backdrop remains soft.
• Cash-flow anomaly: Q2 FY27 operating cash flow of -$661.8M and FCF of -$839.0M versus +$852.1M OCF a year earlier, with accruals at +5.56% of assets — if it doesn't reverse, reported EPS is outrunning cash generation.
• Operating margin compression: 30.6% in Q2 FY27 versus 35.2% YoY means revenue growth is not currently converting into profit growth.
• Liquidity and leverage: only $98.5M of cash, a current ratio of 0.999 and a quick ratio of 0.53 against ~$9.1B of debt (the reported 0.013 debt-to-equity is a data artifact from a missing long-term-debt figure).
• Structural demand risk: GLP-1 usage, moderation among younger consumers and a pressured Hispanic consumer base could cap beer growth for years rather than quarters.

Not a buy here — but the cheapness is real and worth close monitoring. This is a high-quality franchise misjudged by a formula that sees divestiture-driven revenue declines and one distorted cash-flow quarter rather than a 30.9% operating-margin beer business growing shipments 5.5%, paying a 3.1% dividend and trading at ~10x earnings. Against that, the tape is broken (19.1% below the 200-day), operating margin compressed 4.6 points YoY, and cash flow went sharply negative in the latest quarter, so there is no confirmation the bottom is in. The honest read: $118.98 prices in zero growth, which makes it a reasonable place for a patient, income-oriented investor to begin scaling in on evidence (a 50-day reclaim or a successful retest of $110) — not a place to back up the truck today.

Multiple-based and worked from the data: I apply a 13.0x forward P/E to the $11.55 midpoint of FY27 comparable EPS guidance of $11.20–$11.90, giving $150.15, rounded to $150. The 13x is justified as a premium to Molson Coors (~10x) for STZ's superior brand mix and mid-single-digit shipment growth, a discount to Heineken/AB InBev (~14–15x) for the soft U.S. category and weaker cash conversion, and it reconciles a ~3.1% dividend yield plus ~4–6% EPS growth into a ~10–11% expected total return. Cross-checks anchor the number: ~9x EV/EBITDA on ~$3.3B EBITDA against ~$9.0B net debt implies ~$165, while a normalized ~$1.6B FCF at a 7% required yield implies ~$134 — so $150 sits in the upper-middle of that $134–165 band, below the $160.54 analyst consensus.